CRYO CELL INTERNATIONAL INC
No SEC Form 4 filings for $CCEL in the last 30 days.
See all $CCEL insider activity →Cryo-Cell International (CCEL) reported Q3 EPS of $0.16, exceeding estimates by $0.13, with revenue at $7.82M, above consensus. Shares are up 25.29% over 3 months. InvestingPro rates its financial health as 'good performance'.
CRYO CELL INTERNATIONAL INC reported $7.82M in revenue for 3Q FY2026, flat compared to the prior year. Growth in recurring storage fees was offset by fewer new specimen enrollments. The company expanded operational capacity with a new cold storage facility but paused certain initiatives due to a license dispute. Total revenue year-to-date is roughly flat at $23.3M.
Cryo-Cell International reported Q3 revenue of $7.82M, steady year-over-year, with net income rising to $1.27M ($0.16/share) from $749K ($0.09/share) YoY. The company showed improved earnings but no significant revenue growth, according to the company.
Over the past 7 days, AlphAI's AI scored 4 news stories mentioning CCEL (CRYO CELL INTERNATIONAL INC). Coverage has skewed bullish: 2 bullish, 1 neutral, and 1 bearish.
Recent CCEL coverage spans earnings and financial news.
Earnings beat on both EPS and revenue should support near-term sentiment, but the article provides no guidance or forward catalyst beyond the print.
Flat revenue and operational pauses suggest near‑term weakness.
Earnings beat on net income may generate slight buying interest.
The neutral sentiment for CCEL suggests minimal immediate price movement, with limited influence on related sectors.
AlphAI scores every news story that mentions CCEL with an AI model for sentiment and relevance, and aggregates insider trades from CRYO CELL INTERNATIONAL INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Cryo-Cell International (CCEL) reported Q3 EPS of $0.16, exceeding estimates by $0.13, with revenue at $7.82M, above consensus. Shares are up 25.29% over 3 months. InvestingPro rates its financial health as 'good performance'.
3 min readCRYO CELL INTERNATIONAL INC reported $7.82M in revenue for 3Q FY2026, flat compared to the prior year. Growth in recurring storage fees was offset by fewer new specimen enrollments. The company expanded operational capacity with a new cold storage facility but paused certain initiatives due to a license dispute. Total revenue year-to-date is roughly flat at $23.3M.
1 min readCryo-Cell International reported Q3 revenue of $7.82M, steady year-over-year, with net income rising to $1.27M ($0.16/share) from $749K ($0.09/share) YoY. The company showed improved earnings but no significant revenue growth, according to the company.
1 min readThe global Egg Freezing and Embryo Banking Market is projected to grow from USD 4.49 billion in 2024 to USD 11.26 billion by 2030, driven by societal shifts toward delayed parenthood and advancements in cryopreservation. Despite high costs posing a significant challenge, the integration of AI in embryo selection is enhancing success rates and boosting market expansion. Key players include ReproTech, Cryo-Cell, and CCRM Fertility Clinic.
4 min read
